Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review
GD Lopaschuk, S Verma - Basic to Translational Science, 2020 - jacc.org
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review
GD Lopaschuk, S Verma - JACC. Basic to translational …, 2020 - pubmed.ncbi.nlm.nih.gov
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
[HTML][HTML] Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review
GD Lopaschuk, S Verma - JACC: Basic to Translational Science, 2020 - ncbi.nlm.nih.gov
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review.
GD Lopaschuk, S Verma - JACC. Basic to Translational Science, 2020 - europepmc.org
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
[HTML][HTML] Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review
GD Lopaschuk, S Verma - JACC: Basic to Translational Science, 2020 - Elsevier
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
[引用][C] Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
GD Lopaschuk, S Verma - JACC: Basic to Translational Science, 2020 - cir.nii.ac.jp
Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2)
Inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
Inhibitors | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 …
[PDF][PDF] Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
GD Lopaschuk, S Verma - 2020 - cardiacos.net
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
[PDF][PDF] Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
GD Lopaschuk, S Verma - 2020 - scienceopen.com
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
[PDF][PDF] Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors
GD Lopaschuk, S Verma - 2020 - cardiacos.net
Recent clinical trials have shown that sodium glucose co-transport 2 (SGLT2) inhibitors have
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …
dramatic beneficial cardiovascular outcomes. These include a reduced incidence of …